Key result
APPROACH-IS II is a planned global cross-sectional study aiming to enroll 8,000 adults with congenital heart disease to assess patient-reported outcomes and frailty phenotypes.
Why the study?
Understanding of the variability and global experience of patient-reported outcomes in adults with CHD is lacking, and information on epidemiological characteristics and frailty phenotyping in older adults with CHD is minimal.
Cross-Sectional (n=8,000)
Yes
The APPROACH-IS II study is designed to generate a global dataset on patient-reported outcomes and frailty phenotypes in adults with congenital heart disease.
Answers are grounded in this paper and cite their sources.
Aims to generate global PRO and frailty data in ACHD; leaves open prognostic value and management implications.
BACKGROUND: In recent years, patient-reported outcomes (PROs) have received increasing prominence in cardiovascular research and clinical care. An understanding of the variability and global experience of PROs in adults with congenital heart disease (CHD), however, is still lacking. Moreover, information on epidemiological characteristics and the frailty phenotype of older adults with CHD is minimal. The APPROACH-IS II study was established to address these knowledge gaps. This paper presents the design and methodology of APPROACH-IS II. METHODS/DESIGN: APPROACH-IS II is a cross-sectional global multicentric study that includes Part 1 (assessing PROs) and Part 2 (investigating the frailty phenotype of older adults). With 53 participating centers, located in 32 countries across six continents, the aim is to enroll 8000 patients with CHD. In Part 1, self-report surveys are used to collect data on PROs (e.g., quality of life, perceived health, depressive symptoms, autonomy support), and explanatory variables (e.g., social support, stigma, illness identity, empowerment). In Part 2, the cognitive functioning and frailty phenotype of older adults are measured using validated assessments. DISCUSSION: APPROACH-IS II will generate a rich dataset representing the international experience of individuals in adult CHD care. The results of this project will provide a global view of PROs and the frailty phenotype of adults with CHD and will thereby address important knowledge gaps. Undoubtedly, the project will contribute to the overarching aim of improving optimal living and care provision for adults with CHD.
No takes yet. Share an insight, caveat, or question.
Bulck et al. (2022) conducted a cross-sectional in Congenital heart disease (n=8,000). Patient-reported outcomes and frailty phenotyping was evaluated on Patient-reported outcomes and frailty phenotype. APPROACH-IS II is a planned global cross-sectional study aiming to enroll 8,000 adults with congenital heart disease to assess patient-reported outcomes and frailty phenotypes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: